Watson Pharmaceuticals and Actavis, now unified under the Actavis name, merged to become the world's third-largest generics manufacturer, with more than 750 products marketed through operations in more than 60 countries. Integrated by design, the company develops, manufactures, markets, and distributes generic, brand and biologic pharmaceutical products.


Objectives
    ·   Translate the new Actavis identity into a three-dimensional form that reflects the bold essence of the brand
    ·   Create a family of signs for the Actavis corporate offices
    ·   Develop guidelines for signage usage and implementation
 
Responsibilities
    ·   Concept development
    ·   3D rendering
    ·   Material and finish selections
    ·   Guideline development
 
Design Studio: Lippincott (www.lippincott.com)
Back to Top